Χώρα: Ηνωμένο Βασίλειο
Γλώσσα: Αγγλικά
Πηγή: MHRA (Medicines & Healthcare Products Regulatory Agency)
Clomipramine hydrochloride
Sigma Pharmaceuticals Plc
N06AA04
Clomipramine hydrochloride
10mg
Oral capsule
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04030100
PHOBIAS AND OBSESSIVE STATES • Adults: initially 25 mg a day which may be gradually increased if necessary. • Elderly: initially 10 mg a day which may be gradually increased if necessary. This medicine may take up to 4 weeks to work. You may feel more anxious at the start of treatment but this will normally decrease after two weeks. CATAPLEXY ASSOCIATED WITH NARCOLEPSY • Adults (including the elderly): Initially, 10 mg a day which may be gradually increased if necessary, to between 10-75 mg a day. Children and adolescents (0-17 years of age): Clomipramine is not recommended for use in children and adolescents. IF YOU TAKE MORE CLOMIPRAMINE THAN YOU SHOULD If you (or someone else) take too many capsules all together, or if you think a child has swallowed any of the capsules, contact your nearest hospital casualty department or your doctor immediately. An overdose is likely to cause drowsiness, stupor, coma, difficulty in controlling movements, agitation, enhanced reflexes, restlessness, fits, muscular rigidity, involuntary jerky movements, shock, low blood pressure, a fast or abnormal heart rate, vomiting, fever, dilated pupils, breathing problems, sweating, blue colour to the skin, passing little or no urine. Please take this leaflet, any remaining capsules and the container with you to the hospital or doctor so that they know which capsules were consumed. IF YOU FORGET TO TAKE CLOMIPRAMINE If you forget to take a capsule, take one as soon as you remember, unless it is nearly time to take the next one. Do not take a double dose to make up for a forgotten dose. Take the remaining doses at the correct time. IF YOU STOP TAKING CLOMIPRAMINE Do not stop taking Clomipramine suddenly because this may cause withdrawal side effects. If the decision is made by your doctor to discontinue treatment, the dose you receive will be cut down gradually to prevent the development of withdrawal symptoms. You may get these side effects if you stop taking Clomipramine suddenly: feeling or being sick, stomach ache, diarrhoea, hea Διαβάστε το πλήρες έγγραφο
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Clomipramine 10 mg Capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 10 mg clomipramine hydrochloride. For excipients, see 6.1. 3. PHARMACEUTICAL FORM Capsule, hard. Size 4 gelatin capsule, brown cap and yellow body. Printed '1806'. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Clomipramine capsules are indicated for the symptoms of depressive illness, especially where sedation is required, and obsessive and phobic states. Clomipramine capsules are also indicated for cataplexy associated with narcolepsy. CHILDREN AND ADOLESCENTS In children and adolescents, there is not sufficient evidence of safety and efficacy of clomipramine in the treatment of depressive states, phobias and cataplexy associated with narcolepsy. The use of clomipramine in children and adolescents (0-17 years of age) in these indications is therefore not recommended (see section 4.4 Special Warnings and Precautions for use). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Before initiating treatment with clomipramine, hypokalemia should be treated (see 4.4. Special Warnings and Precautions for use). As a precaution against possible QTc prolongation and serotonergic toxicity, adherence to the recommended doses of clomipramine is advised and any increase in dose should be made with caution if other serotonergic agents are co-administered (see sections 4.4 Special Warnings and Precautions for use and 4.5 Interaction with other Medicinal Products and other forms of Interaction). DEPRESSION _Adults_ Initially 10 mg daily, increasing gradually to 30 - 150 mg daily if required, in divided doses throughout the day, or as a single dose at bedtime. In most patients the adequate maintenance dose is 30 - 50 mg daily, although some patients may require higher doses, particularly those suffering from obsessional or phobic disorders. In severe cases the dosage may be increased up to 250 mg per day. Once a distinct improvement has set in, the daily dosage may be adjusted Διαβάστε το πλήρες έγγραφο